Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study

Objective. To compare the real-world effectiveness of everolimus-based therapy and chemotherapy in postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative (HR+/HER2−) metastatic breast cancer (mBC). Methods. This retrospective chart review examined a nat...

Full description

Bibliographic Details
Main Authors: Nanxin Li, Yanni Hao, Jipan Xie, Peggy L. Lin, Valerie Koo, Erika Ohashi, Eric Q. Wu
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2015/240750